Muir-Torre syndrome , MTS (Abkürzung)

Occasional cases may be associated with Muir-Torre syndrome.

Muir-Torre Syndrome is a genetic condition.

Colorectal cancer is the commonest visceral neoplasm in Muir-Torre syndrome patients.

Sebaceous adenomas, in isolation, are not significant; however, they may be associated with Muir-Torre syndrome, a genetic condition that predisposes individuals to cancer.

The phenomenon, also described independently by E. G. Muir, is taught to medical students as the Muir-Torre syndrome.

Seboacanthomas are a cutaneous condition, and a specific type of sebaceous adenoma which may be specific to Muir-Torre syndrome.

The Amsterdam criteria are frequently used to diagnose Lynch syndrome and Muir-Torre syndrome.

A couple studies have been conducted on patients with both Muir-Torre Syndrome and Turcot Syndrome.

South CD, Hampel H, Comeras I, et al.: The frequency of Muir-Torre syndrome among Lynch syndrome families.

A subtype of HNPCC is known as Muir-Torre Syndrome (MTS) which is associated with skin tumors.

Bapat B, Xia L, Madlensky L, et al.: The genetic basis of Muir-Torre syndrome includes the hMLH1 locus.

Suspiro A, Fidalgo P, Cravo M, et al.: The Muir-Torre syndrome: a rare variant of hereditary nonpolyposis colorectal cancer associated with hMSH2 mutation.

Familial adenomatous polyposis (FAP), Gardner Syndrome, Lynch Syndrome, Muir-Torre syndrome, Celiac sprue, Puetz-Jeghers, Crohn's Disease and Juvenile Polyposis Syndrome are risk factors for developing this cancer.

Muir-Torre syndrome is considered a variant of Lynch syndrome, and includes a phenotype of multiple cutaneous adnexal neoplasms (including sebaceous adenomas, sebaceous carcinomas, and keratoacanthomas) and tumors in the small and large bowel, stomach, endometrium, kidney, and ovaries.